Beijing Bohui Innovation Biotechnology Group Co., Ltd. Stock
Equities
300318
CNE000001QR4
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.4 CNY | -2.00% | -0.55% | -13.46% |
Sales 2022 | 796M 110M | Sales 2023 | 1.05B 144M | Capitalization | 5.1B 704M |
---|---|---|---|---|---|
Net income 2022 | -78M -10.77M | Net income 2023 | -24M -3.31M | EV / Sales 2022 | 6.85 x |
Net Debt 2022 | 674M 93.13M | Net Debt 2023 | 702M 96.96M | EV / Sales 2023 | 5.55 x |
P/E ratio 2022 |
-61
x | P/E ratio 2023 |
-205
x | Employees | 1,961 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 37.78% |
1 day | -2.00% | ||
1 week | -0.55% | ||
Current month | +3.65% | ||
1 month | +17.14% | ||
3 months | +20.81% | ||
6 months | -16.80% | ||
Current year | -13.46% |
Managers | Title | Age | Since |
---|---|---|---|
Yan Jiang
CEO | Chief Executive Officer | 54 | 20-03-16 |
Hai Feng Dong
DFI | Director of Finance/CFO | 40 | 20-06-28 |
Jiang Hong Du
CHM | Chairman | 56 | 01-06-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jiang Hong Du
CHM | Chairman | 56 | 01-06-25 |
Jun Ban
BRD | Director/Board Member | 57 | 20-06-28 |
Zhi Wei Shen
CHM | Chairman | 46 | 22-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +3.53% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-22 | 5.4 | -2.00% | 5 416 871 |
24-05-22 | 5.51 | +0.55% | 5,846,000 |
24-05-21 | 5.48 | -1.44% | 6,192,600 |
24-05-20 | 5.56 | +3.35% | 12,007,790 |
24-05-17 | 5.38 | +0.37% | 6,995,699 |
End-of-day quote Shenzhen S.E., May 22, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.46% | 622M | |
-1.62% | 89.22B | |
+1.32% | 40.49B | |
-15.73% | 32.79B | |
+64.13% | 26.23B | |
-21.28% | 14.52B | |
-8.50% | 13.09B | |
-44.07% | 11.6B | |
-13.06% | 11.5B | |
+4.94% | 8.82B |
- Stock Market
- Equities
- 300318 Stock